Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:57 PM UTC
| NCT Number | NCT04641247 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE2 |
| Target Enrollment | 37 participants |
| Active Locations | 13 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | June 24, 2026 (Jun 24, 2026) |
As of October 12, 2026: Clinical trial NCT04641247 is currently recruiting participants. This phase2 study for ovarian cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04641247 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04641247 was last updated Jun 24, 2026 (June 24, 2026). HelloStudys verifies this status automatically.